» Articles » PMID: 8707930

Recognition of Neurokinin 1 Receptor (NK1-R): an Antibody to a Peptide Sequence from the Third Extracellular Region Binds to Brain NK1-R

Overview
Journal J Neuroimmunol
Specialty Neurology
Date 1996 Jun 1
PMID 8707930
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Substance P (SP) can produce cytokine-like responses by astrocytes and mononuclear cells. In an effort to identify neurokinin-1-receptors (NK1-R), an antibody to NK1-R was generated by using a linear peptide sequence from the deduced third extracellular region (ECR) corresponding to the seven transmembrane rat brain NK1-R. The ECR-3 peptide was coupled to keyhole-limpet hemocyanin and the antisera produced in rabbits was purified by binding to a peptide-affinity matrix. The specificity for the anti-peptide antibody was shown by its reactivity to the ECR-3 peptide by ELISA. The anti-ECR-3 peptide antibody could detect, by Western blot analysis of SDS-PAGE-separated rat brain membranes, a single band with an apparent molecular weight (MW) of 53-54 kDa. An affinity matrix made from the anti-ECR-3 antibody was used to isolate NK1-R from rat brain membranes which exhibited two products on SDS-PAGE with apparent MW of 54 and 44 kDa. The C6 astrocytes were shown to express NK1-R as determined by [125I]Bolten-Hunter SP binding to intact cells with a Kd = 0.32 nM. These C6 cells did not co-express either NK2-R or NK3-R when analyzed at the mRNA level. The anti-ECR-3 peptide antibody could inhibit [125I]Bolten-Hunter SP binding to intact C6 astrocytes and CHO cells expressing NK1-R by greater than 95% when compared to normal rabbit IgG which failed to inhibit radiolabeled SP binding. Thus, an antibody which recognizes surface determinants to the NK1-R could be generated upon immunization with an NK1-R peptide.

Citing Articles

The substance P/NK-1 receptor system: NK-1 receptor antagonists as anti-cancer drugs.

Munoz M, Covenas R, Esteban F, Redondo M J Biosci. 2015; 40(2):441-63.

PMID: 25963269 DOI: 10.1007/s12038-015-9530-8.


The role of neurokinin-1 receptor in the microenvironment of inflammation and cancer.

Rosso M, Munoz M, Berger M ScientificWorldJournal. 2012; 2012:381434.

PMID: 22545017 PMC: 3322385. DOI: 10.1100/2012/381434.


Prophylactic and therapeutic targeting of the neurokinin-1 receptor limits neuroinflammation in a murine model of pneumococcal meningitis.

Chauhan V, Kluttz J, Bost K, Marriott I J Immunol. 2011; 186(12):7255-63.

PMID: 21562162 PMC: 3110637. DOI: 10.4049/jimmunol.1100721.


Neurogenic exacerbation of microglial and astrocyte responses to Neisseria meningitidis and Borrelia burgdorferi.

Chauhan V, Sterka Jr D, Gray D, Bost K, Marriott I J Immunol. 2008; 180(12):8241-9.

PMID: 18523290 PMC: 2507752. DOI: 10.4049/jimmunol.180.12.8241.